Page 2
Cardiology/Pre-op
| AFIB: AFFIRM (2002): A Comparison of Rate Control and Rhythm Control in Patients w/Atrial Fibrillati
|
| AFIB: 2019 Afib Mgmnt Update (AHA/ACC/HRS)
|
| EAST-AFNET4 : Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
|
| Heart Failure: 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization
|
| Heart Failure (HFpEF, HFrEF definitions update) #HF2021
|
| Heart Failure Staging (NYHA Symptom Class) #HF
|
| Heart Failure Staging (AHA) A-D #HF2021
|
| Heart Failure 2021: Treatment Algorithm for Guideline-Directed Medical Therapy (GDMT) #HF2021
|
| Heart Failure 2021: GDMT Decision Pathway #HF2021
|
| Heart Failure 2021: Dose Selection for Hydrazaline/Ivabridine #HF2021
|
| Heart Failure 2021: Dose Selection for Diuretics/MRA/SGLT2 #HF2021
|
| Heart Failure 2021: Dose Selection for ARNI/BB/AceI #HF2021
|
| Preop Evaluation - ACC 2014 Guidelines Algorithm summary (Powerpoint)
|
| Preop Evaluation - ACC 2014 Complete Guideline
|
| Preop Evaluation - RCRI Revised Cardiac Risk Index (Lee Criteria)
|
| Preop Evaluation - MACE Risk calculator (gupta score)
|
| Preop Evaluation - Risk Calculator (FACS)
|
| Preop Evaluation - ASA classification Guide (for Gupta Score)
|
| Preop Evaluation - Met Level Capacity Guide
|
| FINEARTS-HF Trial (2024): Finerenone in Patients With a Recent Worsening Heart Failure Event
|
| FINEARTS-HF: Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2025)
|
| FINEARTS-HF: NEJM Quick-Take (2025)
|
| Finerenone Versus Spironolactone for Heart Failure with Preserved Ejection Fraction (2025)
|
| RALES 1999: The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Fa
|
| PARTNER (2011): Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|
| EMPHASIS-HF (2011): Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
|
| PLATO Trial (2009): Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|
| STRONG-HF (2022) : Safety, tolerability and efficacy of up-titration of guideline-directed medical t
|
| PANDA II (2025) : Influenza vaccination to improve outcomes for patients with acute heart failure
|
